Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Experimental pharmacology; Pharmacological research; Behavioral tests; Behavioral analysis; Neurological disorders

Introduction

Behavioral analysis plays a pivotal role in experimental pharmacology, providing valuable insights into the effects of drugs on the Central Nervous System (CNS) and behavior. By examining how drugs influence animal behavior, researchers can elucidate mechanisms of action, assess therapeutic potential, and identify potential side effects. In this article, we explore the principles, methodologies, and applications of behavioral analysis in experimental pharmacology, highlighting its significance in drug discovery and development [1].

Understanding behavioral analysis

Behavioral analysis involves the systematic observation and quantification of animal behavior in response to pharmacological interventions. Animal models, typically rodents such as mice and rats, are used to study a wide range of behaviors relevant to human physiology and pathology [2]. These behaviors encompass locomotor activity, anxiety-like behavior, cognitive function, social interaction, sensory perception, and more. By employing standardized behavioral tests and paradigms, researchers can assess the effects of drugs on specific behavioral domains and gain insights into their pharmacological properties [3].

Methodologies in behavioral analysis

Open field test: The open field test is a widely used paradigm for assessing locomotor activity and exploratory behavior in rodents. Animals are placed in a novel environment, typically an arena with defined boundaries, and their movements are tracked and analyzed. Changes in locomotor activity, rearing behavior, and time spent in the center versus periphery provide insights into the effects of drugs on overall activity and anxiety-like behavior [4,5].

Elevated plus maze: The elevated plus maze is a classic test for evaluating anxiety-like behavior in rodents. The apparatus consists of two open arms and two enclosed arms elevated above the ground. Animals are placed on the maze, and their behavior is recorded as they explore the open and enclosed arms. Changes in the time spent in the open arms versus enclosed arms reflect alterations in anxiety levels induced by pharmacological interventions [6,7].

Morris water maze: The Morris water maze is a paradigm commonly used to assess spatial learning and memory in rodents. Animals are trained to locate a hidden platform submerged in a pool of water using spatial cues [8]. The latency to find the platform and the trajectory followed by the animals provide measures of spatial learning and memory. Pharmacological manipulations can modulate performance in the water maze, revealing the effects of drugs on cognitive function [9].

Social interaction tests: Social interaction tests assess the social behavior of rodents, including social approach, sniffing, and grooming behaviors. These tests are relevant for studying the effects of drugs on social behavior and sociability, which are impaired in neuropsychiatric disorders such as autism spectrum disorders and schizophrenia [10].

Conclusion

Behavioral analysis is an indispensable tool in experimental pharmacology, providing valuable insights into the effects of drugs on behavior and CNS function. By employing standardized behavioral assays, researchers can elucidate pharmacological mechanisms, assess therapeutic potential, and advance drug discovery and development efforts. As our understanding of the complex interplay between drugs, behavior, and brain function continues to evolve, behavioral analysis will remain a cornerstone of experimental pharmacology, driving innovation and improving patient outcomes in neuropsychiatric and neurological disorders.

1. Emwas AH, Szczepski K, Poulson BG, Chandra K, McKay RT, et al. (2020) “Gold Standard” Method in Drug Design and Discovery. Molecules 25: 4597.

Indexed at, Crossref, Google Scholar

2. Li Q, Kang CB (2020) A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery. Molecules 25: 2974.

Indexed at, Crossref, Google Scholar

3. Pellecchia M, Bertini I, Cowburn D, Dalvit C, Giralt E, et al. (2008) Perspectives on NMR in drug discovery: A technique comes of age. Nat Rev Drug Discov 7: 738-745.

Indexed at, Crossref, Google Scholar

4. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274: 1531-1534.

Indexed at, Crossref, Google Scholar

5. Lamoree B, Hubbard RE (2017) Current perspectives in fragment-based lead discovery (FBLD). Essays Biochem 61: 453-464.

Indexed at, Crossref, Google Scholar

6. Harner MJ, Frank AO, Fesik SW (2013) Fragment-based drug discovery using NMR spectroscopy. J Biomol NMR 56: 65-75.

Indexed at, Crossref, Google Scholar

7. Li Q (2020) Application of Fragment-Based Drug Discovery to Versatile Targets. Front Mol Biosci 7: 180.

Indexed at, Crossref, Google Scholar

8. Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nat Chem 1: 187-192.

Indexed at, Crossref, Google Scholar

9. Ayotte Y,  Murugesan JR,  Bilodeau F, Larda S, Bouchard P, et al. (2017) Discovering Quality Drug Seeds by Practical NMR-based Fragment Screening. Protein Sci 26: 194-195.

Google Scholar

10. Erlanson DA, Fesik SW, Hubbard RE, Jahnke W, Jhoti H (2016) Twenty years on: The impact of fragments on drug discovery. Nat Rev Drug Discov 15: 605-619.

Indexed at, Crossref, Google Scholar